Who is behind ClickDose
ClickDose is built by Tue Topholm, a software engineer and founder of Gaijin. Tue is not a medical doctor or pharmacist — he is a patient and family member who built the tool after seeing how hard it is to count clicks accurately on GLP-1 injection pens.
ClickDose started as an open source project to help others using Wegovy, Ozempic, or Mounjaro — especially those splitting doses to extend a pen or titrating slowly to reduce side effects.
Our editorial process
Health content on ClickDose follows these principles:
- Every clinical claim is backed by a primary source — FDA prescribing information, EMA Summary of Product Characteristics (SmPC), or peer-reviewed studies. Sources appear at the bottom of each article.
- Figures and statistics are quoted directly from the manufacturers' official documents (Novo Nordisk for Wegovy/Ozempic, Eli Lilly for Mounjaro).
- Articles are updated when new label revisions are published, or when readers report errors.
- ClickDose is not a medical device. All content is informational — always verify your dose visually on the pen and talk to your doctor.
Seeking medical reviewer
We are actively looking for a pharmacist or physician to review content before publication. If you are a relevant professional interested in collaborating (credited with name and title), please email tt@gaijin.dk.
Contact
Questions, factual corrections, or suggestions: tt@gaijin.dk.
Source code and bug reports: github.com/ttopholm/click-counter.